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The use of haemostatic agents in thyroid surgery: efficacy and further advantages. Collagen-Fibrinogen-Thrombin
Patch (CFTP) versus Cellulose Gauze
AIM: To assess the efficacy of two widely used topical haemostatic agents: oxidised regenerated cellulose gauze and Collagen-
Fibrinogen-Thrombin Patch in patients undergoing total thyroidectomy. 
MATERIAL OF STUDY: This was a prospective, comparative, non-randomised study in which consecutive patients undergo-
ing total thyroidectomy for benign disease received standard treatment with no haemostatic agent, cellulose gauze, or
CFTP. Main outcome measures were drainage volume 24 hours after surgical procedure and the occurrence of post-oper-
ative complications (haematoma, seroma, surgical-site infection). 
RESULTS: Two hundred seventy-one (271) patients undergoing total thyroidectomy for benign disease: 65 received stan-
dard treatment, 60 received cellulose gauze and 146 received CFTP. Seroma was significantly reduced in the CFTP
group compared with both the cellulose gauze group (p=0.006) and the standard treatment group (p=0.017). A signif-
icant reduction in drainage volume was also observed with CFTP compared with the other two groups (both p<0.001).
Drainage volume was also significantly reduced with cellulose gauze versus standard treatment (p<0.001). No septic events
were observed after application of CFTP. One hematoma was observed in the non haemostatic group. 
CONCLUSIONS: Both haemostatic agents reduced the amount of sero-hematic fluid during the first 24 hours post-surgery,
with CFTP more effective than oxidized cellulose gauze. The use of haemostatic agents may increase the quality of thy-
roid surgery, improve patient comfort after surgery, and reduce hospital stay.
KEY WORDS: Surgical haemostasis, Thyroidectomy.
Introduction
Post-thyroidectomy complications, such as vocal cord pal-
sy, permanent hypoparathyroidism, and neck hematoma
can result in severe and even life-threatening injuries,
and thus constitute a major concern for surgeons 1,2.
Post-operative hemorrhage may result in airway com-
pression and respiratory distress, most often as a result
of laryngopharyngeal edema secondary to the impairment
of venous and lymphatic drainage 3. This phenomenon
is caused by blood collecting in a narrow space, which
can make tracheal intubation, often necessary to ensure
the patient’s survival, impossible to perform. The inci-
dence of compressive hematoma after thyroidectomy is
reported in the literature as between 0.5% and 4.3%,
with an average occurrence of around 1% 2,4,5. Effective
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hemostasis is an important goal in thyroid surgery, and
can reduce the risk of post-operative complications.
Various haemostatic techniques and devices are used,
including sutures, ligation, clips, and monopolar and
bipolar diathermy. In addition, various topical haemo-
static agents and tissue adhesives can be used.
Haemostatic products that are available in our operating
room include an equine collagen patch coated with
human fibrinogen and human thrombin (CFTP), and
oxidised regenerated cellulose gauze. Although widely
used, evidence of the efficacy of these products in thy-
roid surgery is limited. The purpose of this prospective
study was to assess and compare the haemostatic effica-
cy of CFTP and cellulose gauze in patients undergoing
thyroidectomy, in terms of blood loss and the incidence
of hemorrhagic events. In addition, we also investigated
whether the use of these products was associated with
other potential benefits.
Materials and methods
Between June 2006 and May 2009, we performed a
prospective, non-randomized, comparative study involv-
ing 271 consecutive patients who were scheduled for
total thyroidectomy at our surgical unit. Patients were
eligible if they had a preoperative diagnosis of benign
thyroid disease, with no signs of malignancy. Exclusion
criteria were a diagnosis of malignancy with need for
lymph node dissection; sub-sternal goiter; abnormal coag-
ulation or drugs that could interfere with hemostasis.
Patients were divided into three groups. Patients in
Group A (65) underwent standard thyroidectomy (total
thyroidectomy), with extremely careful attention paid to
hemostasis and drainage placement, but no additional
haemostatic product. Patients in Group B (60) under-
went a similar procedure, but with the addition of an
oxidized, regenerated, cellulose gauze, which was placed
in the thyroid cavity to cover the trachea and lateral
spaces containing laryngeal nerves, parathyroid glands,
and vessels legated during thyroidectomy. Patients in
Group C (146) also underwent the same standard sur-
gical procedure, but with the application of a medicat-
ed collagen sponge coated with human fibrinogen and
thrombin. The patch could be applied intact, cut into
smaller pieces (5-15 mm2), or rolled-up. Areas at risk
(e.g., above perineural vessels) were always carefully cov-
ered. We preferred use CFTP intact, applying two small
parts near the entrance of recurrent nerve. All three
groups were comparable in terms of patient characteris-
tics and thyroid volume (Table I). The thyroid size was
calculated preoperatively using the following ultrasound
criteria: ld x td x th x 0.5 (ld is the longitudinal diam-
eter of the lobe, td the transverse diameter, th the lobe
thickness, and 0.5 is a correction factor used to trans-
form the obtained amount from a parallelepiped into an
ellipsoid). The calculation of the lobe size was done sep-
arately, and the values were added up later. Patients were
allocated to groups arbitrarily and/or depending on the
availability of tools. Allocation was established by the
surgical team at the beginning of each operation. Patients
were blinded to their group assignment. All patients were
operated on by the same surgical team (two of three sur-
geons, experienced in endocrine neck surgery: G.G., G.S.
and N.C.P.). During the trial, a firm evidence suggest-
ed that CFTP was advantageous in reducing drainage
volume, so patients enrolled in the CFTP group were
much more numerous compared with the other two arms
of the study.
Informed consent was provided by all patients, and no
patient refused to be recruited for the study. Institutional
Ethics Board approval was obtained. All patients under-
went open total thyroidectomy, with an incision size, as
required, between 25 and 45 mm; conventional total
thyroidectomy infact requires an incision size of 40-50
mm. Traditional surgical procedures were carried out
with hemostasis achieved by monopolar coagulator and
knot-tie technique. Near areas at risk for recurrent nerve
or parathyroid damage, bi-polar coagulation was applied
only if ligation was inapplicable and/or unsafe for achiev-
ing hemostasis. Recurrent laryngeal nerves and parathy-
roid glands were always identified. At the end of the
surgery, a single small size (10 Ch) suction drainage tube
was applied to the thyroid cavity. Suction drainage or
other type of drainage like Penrose drain are not rou-
tinely used in conventional thyroid surgery. In this study
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TABLE I - Patient baseline characteristics.
A: Standard treatment (n=65) B: Cellulose gauze (n=60) C: CFTP
(n=146)
Gender (M/F) 14/51 13/47 21/128
Mean age (years) 51.75 53.1 50.73
Mean ± SD thyroid volume 42.12 ± 13.73 41.60 ± 13.09 42.89 ± 12.99
Multinodular goiter (n) 53 49 119
Multinodular toxic goiter (n) 5 4 9
Graves disease (n) 7 7 16
Plummer’s disease (n) 0 0 2
it was in PVC material and used to evaluate the over-
all amount of blood and serum loss after the procedure,
and to assess the actual difference between the groups.
This was removed after 24 hours, and the quantity and
quality of the drained fluid was evaluated. Variables ana-
lyzed were the drainage volume during the first 24 hours
after surgery, and the occurrence of post-operative com-
plications (hematoma, seroma and surgical site infection).
Statistical analysis was performed with SAS software, ver-
sion 9.2. Rates of hematoma, seroma, and surgical site
infection were analyzed with a logistic regression mod-
el. If the test between groups was statistically significant
(p<0.05), multiple paired comparisons were done. The
difference in drainage volume was measured by analysis
of variance (ANOVA).
Results
A summary of our results is reported in Table II.
Drainage volume up to 24 hours after surgery was sig-
nificantly reduced with both CFTP and cellulose gauze
compared with standard treatment (p<0.001for both). In
addition, mean drainage volume in the CFTP group was
significantly less than in the cellulose gauze group
(p<0.001) (Fig. 1). Seroma, appearing usually 3-5 days
after surgery, was also significantly different between
groups (p=0.003). Seroma was significantly less frequent
in the CFTP group compared with either standard treat-
ment (p=0.017) or cellulose gauze (p=0.006). The dif-
ference in occurrence of seroma in group B vs group A
was not statistically significant. No significant differences
between the groups were observed for the occurrence of
compressive hematoma, which occurred in only one
patient who was undergone immediate surgical reopera-
tion with quickly hemostats control, or surgical site infec-
tion, which was observed in a single patient in both the
standard care and cellulose gauze groups. All patients
underwent clinical and ultrasonographic control after 2-
4 weeks with the aim to obtain a more homogeneous
groups and verify the complete absorption of the patch
and/or the presence of collections into the surgical site.
Discussion
Hemorrhage is an uncommon, but serious, complication
of thyroidectomy that can result in life-threatening air-
way obstruction through impaired venous and lymphat-
ic drainage, leading to laryngopharyngeal edema 3.
Hemorrhagic symptoms include the sensation of neck
pressure or pain, dysphagia, dyspnea, stridor, and respi-
ratory distress. These symptoms typically occur early in
the post-operative period, often within 6 hours after
surgery 6,7. In one large-scale retrospective review, the
time from thyroidectomy to symptom onset was less than
6 hours in 43% of cases, between 7 and 24 hours in
38%, and beyond 24 hours in 19% of cases 8. If symp-
toms appear, immediate intubation and surgical re-explo-
ration are needed in order to avoid complete airway
obstruction 6. The origin of hemorrhage can be the open-
ing of a previously coagulated vessel, slipping of a liga-
tion, or bleeding from residual thyroid tissue. However,
in some cases it is impossible to determine the source
of bleeding, and surgical re-exploration does not show
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TABLE II - Occurrence of hematoma: seroma and surgical site infection and drainage volume in post-thyroidectomy patients
Hematoma Seroma Surgical Drainage (ml)*
n (%) n (%) site infection Mean ± SD
n (%)
A: Standard treatment (n=65) 1 (1.5) 6 (9.2) 1 (1.5) 92.11 ± 15.32
B. Cellulose gauze (n=60) 0 (0.0) 7 (11.7) 1 (1.7) 82.58 ± 13.61
C: CFTP (n=146) 0 (0.0) 2 (1.4) 0 (0.0) 55.68 ± 12.77
Differences between groups: p=0.238 p=0.003 p=0.211 p<0.001
Standard treatment vs. cellulose gauze p=0.656 p<0.001
Standard treatment vs. CFTP p=0.017 p<0.001
Cellulose gauze vs. CFTP p=0.006 p<0.001
*Drainage up to 24 hours post-surgery.
Fig. 1: mean ± Standard Deviation (SD) drainage volume (up to 24
hours post-surgery) in post-thyroidectomy patients.
any hemorrhagic cause after the hematoma has been
drained 2,3,6-8). Risk factors for post-operative bleeding,
apart from a defined coagulopathy, are not well known.
Several studies have evaluated factors often associated
with post-thyroidectomy cervical hematoma, such as
hyperthyroidism, especially that associated with Graves
disease 2,7,9-12, extent of surgery 8,13, re-operations 14,
malignancy 8,15-16, and large and/or sub-sternal goiters
12,17, but results are contradictory and often not statisti-
cally significant. Aspects of surgical technique, such as
not sectioning the pre-thyroid muscles, or the use of
minimally invasive or endoscopic techniques 3,18-19, can
reduce the risk of hemorrhage. The use of such instru-
ments as the harmonic scalpel, and radiofrequency or
thermal devices, also improves vessel sealing 20 though
further randomized studies are needed to assess their
capacity to prevent major hemorrhagic complications in
thyroid surgery 3. The ability of suction drainage to
reduce the incidence of post-thyroidectomy hemorrhage
is a debated topic. As hemorrhagic complications are
rare, but feared, the insertion of one or two drains is a
generally accepted procedure. However, recent studies
have suggested that suction drainage does not detect
bleeding or prevent respiratory distress, and can some-
times lead to hemorrhage 21-22. Moreover, use of drains
can lengthen post-operative hospital stay, increase the risk
of surgical site infection, and delay the patient’s return
to normal activities 21. The first step in preventing hem-
orrhagic complications is meticulous hemostasis during
surgical procedures. In addition, several topical products
are available to help the surgeon achieve hemostasis,
though there is only limited evidence that these tools
help prevent post-thyroidectomy hemorrhaging. Products
we use in our center include oxidized cellulose gauze and
CFTP, both of which are widely used. The haemostatic
mechanism of bio-absorbable oxidized cellulose gauze is
not well known, though it is believed that the cellulose
gauze forms a coagulum of cellulosic acid salts that link
hemoglobins, resulting in clot formation after contact
with bleeding tissue 23. The clot is then degraded and
absorbed within a maximum period of 7 days. Oxidized
cellulose gauze is deemed to have a bacteriostatic effect
24, but the possibility of a foreign body reaction 25,
though limited, could have undesirable effects, such as
an increase in the incidence of seroma, as observed in
this study. CFTP is a collagen sponge coated on one
side with human fibrinogen and thrombin, the use of
which results in tissue adhesion and sealing. It is acti-
vated by moisture on application, and requires less than
4 minutes to exert its effect; it is enzymatically degrad-
ed and safely absorbed by the body within 12 weeks of
application 26. CFTP is indicated in adults for support-
ive treatment in surgery for improvement of hemostasis,
promotion of tissue sealing, and for suture support in
vascular surgery in which standard techniques are insuf-
ficient. In addition, it is widely used in abdominal (open
and laparoscopic) and thoracic surgery. The use of
absorbable topical haemostatic agents has been assessed
in several studies across different surgical fields 27-30.
These tools are generally accepted as an improvement in
hemostasis of the thyroid bed after a thyroidectomy 3,
31-32, but their real efficacy is uncertain, and their use is
principally based on a cautious approach towards hem-
orrhagic control rather than robust data showing real
advantages. In this study, no hemorrhagic complications
occurred in patients treated with cellulose gauze or CFTP.
However, one hematoma was observed in the standard
care group, in a patient who received no topical haemo-
static agent. The limited occurrence of hemorrhagic
events suggests that it is not possible to confirm the
capacity of topical haemostatic agents to prevent this
complication. Our results show a significant reduction
in drainage volume with both CFTP and oxidized cel-
lulose gauze. This could indicate a capacity to prevent
or reduce the incidence of bleeding in thyroid surgery.
In addition, we also observed other advantages in the
CFTP group, namely a significant reduction in seroma
and no local surgical site infection. Postoperative sero-
ma may result from thyroid surgery. It is generally con-
sidered a minor complication, but it needs a clinical fol-
low-up. Large seromas need aspiration under sterile con-
ditions and repeated aspirations may be necessary. This
complication can be contaminated by pathogens that
could be present on the skin and can lead to surgical
site infection. Seroma occurs in 2 to 7% of thyroidec-
tomies 1. It may lead to readmission, re-intervention,
antibiotic therapy, repeated medications, which correlate
with increased morbidity and costs 33. Surgical site infec-
tion after thyroid surgery generally occurs in 0.9% - 3.2%
of patients. This may be related to pre- and intra-opera-
tive antiseptic precautions and procedures, as well as not
well-known local and systemic factors 1,34-37. In the cellu-
lose gauze group, the incidence of seroma was significant-
ly higher than in the CFTP group. The occurrence of sur-
gical site infection that we observed in the cellulose gauze
group, and in the non-haemostatic group, appeared to be
sporadic, and not statistically significant. Despite these
results, we estimate that the increase in the amount of
drainage fluid and, in particular, the occurrence of seroma
may constitute a predisposition to septic complications.
However, foreign-body reactions have been described else-
where after cellulose gauze application 38. Though this study
involved a large series of patients for more than two years,
larger series of patients evaluated in longer observation peri-
ods, and/or in multicentric studies, and in randomized tri-
als are needed to assess the efficacy of haemostatic agents
in reducing the incidence of compressive hematoma after
thyroid surgery. In our study, both haemostatic agents pro-
vided a significant reduction of drainage fluid in the first
24 hours after surgery, suggesting they are effective in
improving surgical haemostasis. Of the two agents evalu-
ated, CFTP showed clear advantages over cellulose gauze
in reducing drainage volume and seroma, which led us to
use this agent more extensively. 
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Conclusions
According to our experience, the use of CFTP as haemo-
static agent may improve the comfort of patients’ post-
operative hospital stay, as well as reduce their length of
stay, and allow for more rapid resumption of normal
daily activities. In this sense, improved quality of surgery
leads directly to an improved quality of patients’ lives.
Moreover, this may facilitate the option of one-day
surgery, with attendant quality-of-life improvements, and
cost-benefits, for health care systems. Moreover, a more
great casuistry is need to certificate real and effective
reduction of hemorrhagic complication.
Riassunto
Un obiettivo fondamentale in chirurgia tiroidea è
l’ottenimento di un’emostasi efficace per ridurre il
rischio di complicanze potenzialmente pericolose per la
vita del paziente, come l’ematoma compressivo. Scopo
del nostro lavoro è valutare l’efficacia di due agenti
emostatici locali ampiamente utilizzati: una garza di cel-
lulosa ossidata rigenerata e un patch di collagene-fibri-
nogeno e trombina (CFTP) in pazienti sottoposti a
tiroidectomia totale. Il nostro è uno studio prospetti-
co, comparativo, non randomizzato in cui pazienti sot-
toposti a tiroidectomia totale per patologia benigna han-
no ricevuto un trattamento chirurgico tradizionale, sen-
za l’utilizzo di alcun agente emostatico, garza di cellu-
losa o CFTP. I paramenti principalmente utilizzati sono
stati il volume del drenaggio nelle 24 ore dopo tratta-
mento chirurgico e la comparsa di eventuali compli-
canze post-operatorie (ematoma, sieroma, infezione del
sito chirurgico). Abbiamo arruolato 271 pazienti, di cui
65 hanno ricevuto un trattamento chirurgico standard,
60 sono stati operati con l’ausilio della garza di cellu-
losa, e su 146 pazienti abbiamo applicato il CFTP. La
comparsa di sieroma è stata significativamente inferio-
re nel gruppo in cui era stato utilizzato il CFTP con-
frontato sia con il gruppo che aveva ricevuto la garza
di cellulosa (p=0.006) sia con il gruppo sottoposto a
trattamento chirurgico tradizionale (p=0.017).
Un’evidente riduzione del volume del drenaggio è sta-
to inoltre osservato nel gruppo con CFTP confrontato
con gli altri due gruppi (p<0.001). Il volume del dre-
naggio si è ridotto in modo significativo anche nel
gruppo della garza di cellulosa rispetto al trattamento
tradizionale (p<0.001). Nessun evento settico è stato
osservato dopo l’applicazione del CFTP. Si è verificato
un solo caso caso di ematoma nel gruppo in cui non
è stato utilizzato alcun emostatico. Entrambi gli agen-
ti emostatici utilizzati hanno determinato una riduzio-
ne della quota di materiale siero-ematico nelle imme-
diate 24 ore post-operatorie; nello specifico, il CFTP
si è dimostrato più efficace rispetto alla garza di cellu-
losa. L’uso degli agenti emostatici può incrementare la
qualità della chirurgia tiroidea, migliorando il confort
post-operatorio e riducendo la durata della degenza
ospedaliera.
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